Particle.news

Download on the App Store

FXYD2 Marker Enables Precise Selection of Mature Islets That Reverse Hyperglycemia in Diabetic Models

FXYD2 doubles as a membrane-bound regulator of β cell ion channels, enabling precise selection of high-quality islets for transplantation.

Image

Overview

  • Researchers demonstrated that FXYD2 expression distinguishes mature β cells by modulating ion channel activity and fine-tuning insulin secretion dynamics.
  • The study combined single-cell RNA sequencing, electrophysiological assays and imaging to map FXYD2’s dual role in β cell maturation.
  • Stem cell–derived islet organoids were classified into FXYD2-high and FXYD2-low subsets, with FXYD2-high cells showing superior functional profiles.
  • Transplanting FXYD2-high, insulin-positive islets consistently restored normal blood sugar levels in severe diabetic animal models.
  • This discovery provides a quality-control tool for regenerative diabetes therapy by improving the selection of transplant-ready islet grafts.